Archives

by in
Entry Author Date Location
Genomes-R-Us: Is BGI now Complete? 09/25/12 Boston
Roche Deal With Tiny Sunnyvale Biotech Revives Old Family Ties 09/25/12 San Francisco
Roche Picks New Big Apple Tower as Home for Research Center 09/21/12 New York
The FDA Turns Friendly Toward Pharma in 2012 09/10/12 National
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Genentech, ImmunoGen Breast Cancer Drug Extends Lives 08/27/12 San Francisco
Alzheimer’s R&D Isn’t Doomed, it’s Learning From Failure 08/20/12 National
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
The Case for Including Investors on Conference Calls 07/31/12 National
Xconomy Boston’s Top 20 Stories of Q2 2012: Editor’s Picks 07/03/12 Boston
NJ Shocker: Roche to Shutter Nutley R&D Site 06/26/12 New York
Roche Deal Gives Seaside a Leg Up in Autism Race 06/26/12 Boston
Bullhorn, Seaside, Sand 9, & More in the Boston Deals Roundup 06/20/12 Boston
Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug 06/07/12 San Francisco
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Blazes New Trail 06/03/12 San Francisco
Vertex, N-of-One, Flexion & More Boston Life Sciences News 06/01/12 Boston
Genentech, Roche Find New Balance Three Years Post-Merger 05/29/12 San Francisco
Theraclone Passes First Clinical Test with Flu-Fighting Antibody 05/15/12 Seattle
Genomic Health, OncoMed Team Up on Personalized Cancer Drug Work 05/02/12 San Francisco
What Are the Hottest Targets in Biotech Today? 04/23/12 National
SD Life Sciences Roundup: Accelrys, Illumina, & RainTree Oncology 04/19/12 San Diego
Illumina Stays Independent, Roche Walking Away 04/18/12 San Diego
SD Life Sciences Roundup: Optimer, Illumina, & Deals, Deals, Deals 04/12/12 San Diego
BioPharma Needs A Safe, Reliable Way To Repair Broken Genes 04/11/12 Seattle
SD Life Sciences Roundup: Illumina, Sophiris Bio, & New Funding Deals 04/05/12 San Diego
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Clears Big Hurdle 03/30/12 San Francisco
Roche Raises Illumina Takeover Bid to $51/Share 03/29/12 San Diego
DecisionView Looks to Help Speed Up Pharma’s Painfully Slow Trials 03/27/12 San Francisco
Biotech’s New Frontier: Europe? 03/19/12 National
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals 03/12/12 National
Page 2 of 12 « previous page · next page »